Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver

References

• ANTIGNAC, E., FUKUHARA, M., KIMURA, M. and USHIO, F., 1992, Clotrimazole-induced modulation of hepatic cytochrome P450 enzymes in Syrian and Chinese hamsters. Biochemical Pharmacology, 44, 2266–2270.
   Google Scholar
• BAILEY, D. G., ARNOLD, J. M. O. and SPENCE, J. D., 1994, Grapefruit juice and drugs: how significant is the interaction? Clinical Pharmacokinetic s, 26, 91–98.
   Google Scholar
• BAILEY, D. G., BE,, J. R., ARNORD, J. M. O., TRAN, L. T. and SPENCE, J. D., 1996, Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clinical Pharmacology and Therapeutics, 60, 25–33.
   Google Scholar
• BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• BURKE, M. D. and MAYER, R. T., 1974, Ethoxyresorufin: direct fluorometric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthiene. Drug Metabolism and Disposition, 2, 583–588.
   PubMed Web of Science ®Google Scholar
• CORCOS, L .,1992, Phenobarbitaland dexamethasone induce expression of cytochrom eP-450 genes from subfamilies JIB, TIC, and IIIA in mouse liver. Drug Metabolism and Disposition, 20, 797–801.
   PubMed Web of Science ®Google Scholar
• DE WAZIERS, I., CUGNENC, P. H., YANG, C. S., LEROUX, J.-P. and BEAUNE, P. H., 1990, CytochromeP450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. The Journal of Pharmacology and Experimental Therapeutics, 253, 387–394.
   Google Scholar
• DUCHARME, M. P., WARBASSE, L. H. and EDWARDS, D. J., 1995, Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clinical Pharmacology and Therapeutics, 57, 485–491.
   PubMed Web of Science ®Google Scholar
• EDWARDS, D. J., BELLEVUE III, F. H. and WOSTER, P.M., 1996, Identification of 6',7'-dihydroxy-bergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metabolism and Disposition, 24, 1287–1290.
   PubMed Web of Science ®Google Scholar
• FUHR, U. and KUMMERT, A. L., 1995, The fate of naringin in humans: a key to grapefruit juice—drug interactions? Clinical Pharmacology and Therapeutics, 58, 365–373.
   Google Scholar
• FUHR, U., KLITTICH K. and STAIB, A. H., 1993, Inhibitory effect of grapefruit juice and active component,naringenin,on CYP1A2 dependentm etabolism of caffeine. British Journal of Clinical Pharmacology, 35, 431–436.
   Google Scholar
• FUKUDA, K., OHTA, T. and YAMAZOE, Y., 1997, Grapefruit component interacting with rat and human P450 CYP3A: possible involvementof non-flavonoid components in drug interaction. Biological and Pharmaceutical Bulletin, 20, 560–564.
   PubMed Web of Science ®Google Scholar
• GOMEZ, D. Y., WACHER V. J., TOMLANOVICH, S. J., HEBERT, M. F. and BENET, L. Z., 1995, The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clinical Pharmacology and Therapeutics, 58, 15–19.
   Google Scholar
• HEBERT, M. F., ROBERTS, J. P., PRUEKSARITANONT, T. and BENET, L. Z., 1992, Bioavailability of cyclosporine with concomitant rifam pin administration is markedly less than predicted by hepatic enzyme induction. Clinical Pharmacology and Therapeutics, 52, 453–457.
   PubMed Web of Science ®Google Scholar
• KANG, M. H., WON, S. M., PARK, S. S., KIM, S. G., NOVAK, R. F. and KIM, N. D., 1994, Piperine effects on the expression of P4502E1, P4502B and P4501A in rat. Xenobiotica, 24, 1195–1204.
   PubMed Web of Science ®Google Scholar
• KOLARS, J. C., AWNI W. M MERION, R. M. and WATKINS, P. B., 1991, First-pass metabolism of cyclosporin by the gut. Lancet, 338, 1488–1490.
   Google Scholar
• KUPFERSCHMIDT, H. H. T., HA, H. R., ZIEGLER, W. H., MEIER, P. J. and KRÄHENBCHL 5., 1995, Interaction between grapefruit juice and midazolam in humans. Clinical Pharmacology and Therapeutics, 58, 20–28.
   Google Scholar
• LAEMMLI U. K.,1970, Cleavageof structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LUBET, R. A., MAYER, R. T., CAMERON, J. W., Ns, R. W., BURKE, M. D., WOLFF, T. and GUENGERICH F. P.,1985, Dealkylationof pentoxyresorufin: a rapid and sensitive assay for measuringinduction of cytochrome(s)P-450 by phenobarbitaland other xenobioticsin the rat. Archives of Biochemistry and Biophysics, 238, 43–48.
   Google Scholar
• MATSUURA, Y., KOTANI, E., IED, T., FUKUDA, T., TOBINAGA S., YOSHIDA, T. and KUROIWA, Y., 1991, Structure—activity relationships in the induction of hepatic microsom al cytochrome P450 by clotrimazole and its structurally related compounds in rats. Biochemical Pharmacology, 41, 1949–1956.
   Google Scholar
• MUTO, N., TAZAWA, M., ITOH, N. and TANAKA, K., 1995, Piperine enhances the activity and expression of cytochrome P450 in the small intestine mucosae of mice and rats. Japanese Journal of Food Chemistry, 2, 36–41.
   Google Scholar
• NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416–421.
   PubMed Web of Science ®Google Scholar
• NERURKAR, P. V., PARK, S. S., THOMAS, P. E., NS, R. W. and LUBET, R. A., 1993, Methoxyresorufin and benzyloxyresorufin: substrates preferentiallymetabolized by cytochromesP4501A2 and 2B, respectively, in the rat and mouse. Biochemical Pharmacology, 46, 933–943.
   PubMed Web of Science ®Google Scholar
• PARKINSON, A., 1996, Biotransformation of xenobiotics. In Casarett and Doull' s Toxicology : The Bask Science of poisons, edited by C. D. Klaasen (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• RODRIGUES, A. D., LEWIS, D. F., IOANNIDES, C. and PARKE, D. V., 1987, Spectral and kinetic studies of the interaction of imidazoleanti-fungal agents with m icrosom al cytochrome P-450. Xenobiotka, 17, 1315–1327.
   Web of Science ®Google Scholar
• RONIS, M. J. J., INGELMAN -SUNDBERG, M. and BADGER, T. M., 1994, Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochemical Pharmacology, 48, 1953–1965.
   Google Scholar
• ROSENBERG, D. W., 1991, Dietary modulation of cytochrome P450 in the small intestinal epithelium. Pharmacology, 43, 36–46.
   PubMed Web of Science ®Google Scholar
• THIENPONT, D., VAN CUTSEM J., VAN CAUTEREN, H. and MARSBOOM, R., 1981, The biological and toxicological properties of imazalil. Arzneimittel -Forschung /Drug Research, 31, 309–315.
   Google Scholar
• THUMMEL, K.E.,0' SHEA, D., PAINE, M. F., SHEN, D.D.,KuNzE,K. L., PERKINS, J. D. and WILKINSON,G. R., 1996, Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clinkal Pharmacology and Therapeutics, 59, 491–502.
   Google Scholar
• VAN DEN BOSSCHE, H., MARICHAL, P., GORRENS, J., COENE M .-C WILLEMSENS, G., BELLENS, D., ROELS I., MOEREELS, H. and JANSSEN, P. A. J., 1989, Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses, 32 (suppl. 1), 32–52.
   Google Scholar
• VAN DEN BOSSCHE, H., WILLEMSENS, G., COOLS, W., LAUWERS, W. F. J. and LE JEUNE, L., 1978, Biochemicaleffects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albkans Chem:co -Biological Interactions, 21, 59–78.
   Google Scholar
• WATKINS, P. B., 1992, Drug metabolism by cytochrome P450 in the liver and small bowel. Gastroenterolog y Clinics of North America, 21, 511–526.
   PubMed Web of Science ®Google Scholar
• YOSHIDA, Y. and AOYAMA, Y., 1987, Interaction of azole antifungal agents with cytochrome P-45014Dm purified from Saccharomyces cerevisiae microsom es. Biochemical Pharmacology, 36, 229–235.
   PubMed Web of Science ®Google Scholar